Lite Strategy (LITS) Current Leases (2020 - 2024)
Lite Strategy (LITS) posted Current Leases of $1.1 million for Q1 2024, up 3.65% on a QoQ basis from $1.0 million in Q4 2023, and down 24.04% year-over-year from $1.4 million in Q2 2023.
Analysis
Lite Strategy (LITS) Current Leases (2020 - 2024) Analysis & Trends
Lite Strategy has reported Current Leases for 5 years, with the latest figure at $1.1 million in Q1 2024.
- On a quarterly basis, Current Leases fell 24.04% year-over-year to $1.1 million in Q1 2024; TTM through Mar 2024 was $1.1 million, a 24.04% decrease from a year earlier, with the FY2023 full-year figure at $1.4 million, up 63.95% from the prior year.
- Current Leases was $1.1 million for Q1 2024 at Lite Strategy, up from $1.0 million in the prior quarter.
- The five-year high for Current Leases was $1.4 million in Q2 2023, with the low at $602000.0 in Q3 2020.
- Average Current Leases over 5 years is $1.0 million, with a median of $987000.0 recorded in 2021.
- The largest YoY upside for Current Leases was 67.27% in 2023 against a maximum downside of 24.42% in 2023.
- Over 5 years, Current Leases stood at $873000.0 in 2020, then increased by 13.06% to $987000.0 in 2021, then surged by 36.07% to $1.3 million in 2022, then retreated by 24.42% to $1.0 million in 2023, then advanced by 3.65% to $1.1 million in 2024.
- The last three Current Leases figures came in at $1.1 million (Q1 2024), $1.0 million (Q4 2023), and $1.1 million (Q3 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 720.00 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 11.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 12.38 Mn |
| 10 | Lite Strategy | 38.03 Mn | 30.49 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 1.05 Mn |
| Dec 31, 2023 | 1.02 Mn |
| Sep 30, 2023 | 1.06 Mn |
| Jun 30, 2023 | 1.43 Mn |
| Mar 31, 2023 | 1.39 Mn |
| Dec 31, 2022 | 1.34 Mn |
| Sep 30, 2022 | 1.30 Mn |
| Jun 30, 2022 | 871,000.00 |
| Mar 31, 2022 | 828,000.00 |
| Dec 31, 2021 | 987,000.00 |
| Sep 30, 2021 | 957,000.00 |
| Jun 30, 2021 | 928,000.00 |
| Mar 31, 2021 | 900,000.00 |
| Dec 31, 2020 | 873,000.00 |
| Sep 30, 2020 | 602,000.00 |